Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2022 Nov 8:2022.03.23.22272807.
doi: 10.1101/2022.03.23.22272807.

Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19 related olfactory disorders

Affiliations

Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19 related olfactory disorders

Stephanie R Hunter et al. medRxiv. .

Update in

Abstract

It is estimated that 20-67% of those with COVID-19 develop olfactory disorders, depending on the SARS-CoV-2 variant. However, there is an absence of quick, population-wide olfactory tests to screen for olfactory disorders. The purpose of this study was to provide a proof-of-concept that SCENTinel 1.1, a rapid, inexpensive, population-wide olfactory test, can discriminate between anosmia (total smell loss), hyposmia (reduced sense of smell), parosmia (distorted odor perception), and phantosmia (odor sensation without a source). Participants were mailed a SCENTinel 1.1 test, which measures odor detection, intensity, identification, and pleasantness, using one of four possible odors. Those who completed the test (N = 381) were divided into groups based on their self-reported olfactory function: quantitative olfactory disorder (anosmia or hyposmia, N = 135), qualitative olfactory disorder (parosmia and/or phantosmia; N = 86), and normosmia (normal sense of smell; N = 66). SCENTinel 1.1 accurately discriminates quantitative olfactory disorders, qualitative olfactory disorders, and normosmia groups. When olfactory disorders were assessed individually, SCENTinel 1.1 discriminates between hyposmia, parosmia and anosmia. Participants with parosmia rated common odors less pleasant than those without parosmia. We provide proof-of-concept that SCENTinel 1.1, a rapid smell test, can discriminate quantitative and qualitative olfactory disorders, and is the only direct test to rapidly discriminate parosmia.

Keywords: Anosmia; hyposmia; parosmia; phantosmia; prediction; smell test.

PubMed Disclaimer

Conflict of interest statement

Competing interests On behalf of the authors of this manuscript, the Monell Chemical Senses Center and Temple University have been awarded patent protection (US patent no 11,337,640) and this patent has been licensed to Ahersla Health, Inc. The authors may benefit financially through their institution’s patent policy.

Figures

Figure 1.
Figure 1.
Validation of the original SCENTinel 1.0 classification model. SCENTinel 1.1-discriminated anosmia and normosmia in a COVID-19-related population (teal color; n = 51 with anosmia, 66 with normosmia) were well fitted to the original SCENTinel 1.0 classification model. Melon color refers to the model performance of SCENTinel 1.0 with the original sample (n = 111 with anosmia, 154 with normosmia). False positive and true positive rates corresponds to the performance of the classification model to accurately predict an individual as someone with ‘anosmia’ or someone with ‘normosmia’ based on their SCENTinel results.
Figure 2.
Figure 2.
Receiver operating characteristic (ROC) curves and statistics on SCENTinel 1.1 scores overall and for single subtests across groups based on the linear discriminant analysis algorithm: (A) individuals with normosmia (n = 66) versus quantitative dysfunction (n = 135); (B) individuals with quantitative dysfunction versus qualitative dysfunction (n = 86); (C) individuals with normosmia versus qualitative dysfunction. Quantitative dysfunction encompasses individuals with anosmia or hyposmia; qualitative dysfunction includes individuals with parosmia and/or phantosmia. Intensity and hedonics are continuous. AUC, area under the curve; p, p-value; D, DeLong’s test for 2 ROC curves; df, degrees of freedom.
Figure 3.
Figure 3.
Investigation of the hedonic score across individuals with or without parosmia. A) Comparison of average hedonic score across individual smell groups (n = 84 with hyposmia, 66 with normosmia, 66 with parosmia). B) Relationship between hedonic score and frequency of parosmia events (determined via participant’s response to “How often have you experienced smells being distorted or don’t smell like they used to?”; n = 66). C) Comparison of average hedonic score per odor across those with and without parosmia (n = 150 without parosmia, 66 with parosmia). D) Comparison of average hedonic rating and vomit rating across those with and without parosmia. Errors bars indicate standard deviation.
Figure 4.
Figure 4.
Summary of participants in the current study. Final smell group classifications (quantitative, qualitative, mixed, and normosmia) were based on the self-report answers to the question stated. Quantitative smell disorders are classified as those with a change in the perceived intensity of odors. Qualitative smell disorders include those where the perceptual quality or identity of an odor has changed. Thick-lined and dashed boxes are used in the final analyses.

Similar articles

References

    1. Rawal S, Hoffman HJ, Bainbridge KE, Huedo-Medina TB, Duffy VB. Prevalence and risk factors of self-reported smell and taste alterations: results from the 2011–2012 US national health and nutrition examination survey (NHANES). Chem Senses. 2016. Jan;41(1):69–76. - PMC - PubMed
    1. Bonfils P, Avan P, Faulcon P, Malinvaud D. Distorted odorant perception: analysis of a series of 56 patients with parosmia. Arch Otolaryngol Head Neck Surg. 2005. Feb;131(2):107–12. - PubMed
    1. Hummel T, Whitcroft KL, Andrews P, Altundag A, Cinghi C, Costanzo RM, et al. Position paper on olfactory dysfunction. Rhinology. 2016. Jan 31;56(1):1–30. - PubMed
    1. Croy I, Nordin S, Hummel T. Olfactory disorders and quality of life--an updated review. Chem Senses. 2014. Mar;39(3):185–94. - PubMed
    1. Gerkin RC, Ohla K, Veldhuizen MG, Joseph PV, Kelly CE, Bakke AJ, et al. Recent smell loss is the best predictor of COVID-19 among individuals with recent respiratory symptoms. Chem Senses [Internet]. 2020. Dec 25 [cited 2021 Feb 11];(bjaa081). Available from: 10.1093/chemse/bjaa081 - DOI - PMC - PubMed

Publication types